BioSpace News Archive

Hemostemix Announces Closing of UNIT Private Placement

The Offering consisted of the issuance of an aggregate of 8,606,071 Units at a price of $0.14 per Unit.

March 1, 2022
·
8 min read
Cardiol Therapeutics Receives Clearance from the FDA and Regulatory Agencies in Brazil and Mexico for Important Protocol Amendments Designed to Expedite Patient Enrollment in the LANCER Trial

LANCER Trial expanded to include up to 20 Additional Clinical Research Centers.

March 1, 2022
·
7 min read
Pharm Country

Halberd’s COVID-19 Antibody is the Only One In Competitive Tests to Bind to Omicron Variant

Halberd Corporation’s (OTC Pink: HALB) previously developed SARS-CoV-2 antibody demonstrated superior binding capability to the SARS-CoV-2 Omicron variant disease antigen.

March 1, 2022
·
4 min read
BioMark Provides the Third Quarter Operational Update and 2022 Outlook

BioMark completed lab equipment installation and started calibration of its system with vendors for its Quebec-based lab facilities.

March 1, 2022
·
5 min read
Hemostemix Announces Stock Options Grant

The Compensation Committee and Board of Directors of the Company have approved the Options grant and no materially contrary view or ‎abstention ‎was expressed or made by any director in relation to the Options grant

March 1, 2022
·
7 min read
Amrita University launch wearable device for home monitoring of glucose and BP

Amrita University has developed a device for home-monitoring of glucose and blood pressure.

March 1, 2022
·
2 min read
Bio NC

G1 Therapeutics to Participate in the 42nd Annual Cowen Health Care Conference and the 34th Annual Roth 2022 Conference

G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that the Company will participate in two upcoming investor conferences in March 2022.

March 1, 2022
·
1 min read
Business

Immunicom Appoints Jennifer Haldeman as Vice President of Commercial Operations

Immunicom, Inc. today announced Jennifer “J.D.” Haldeman has joined the company as Vice President of Commercial Operations.

March 1, 2022
·
3 min read
Median Technologies to Participate in the Cowen’s 42nd Annual Health Care Conference

Median Technologies, will be participating in the Cowen’s 42nd Annual Health Care Conference, taking place virtually on March 7-9, 2022.

March 1, 2022
·
2 min read
Business

Papyrus Therapeutics Announces Formation of Scientific Advisory Board

Papyrus Therapeutics Inc. announces the formation of its Scientific Advisory Board [SAB].

March 1, 2022
·
3 min read